FACULTAD DE CIENCIAS
Facultad/Centro de investigación
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (22)
2024
2023
-
CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
Pharmaceutics, Vol. 15, Núm. 12
-
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pharmaceutics, Vol. 15, Núm. 5
2022
-
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
International journal of molecular sciences, Vol. 23, Núm. 15
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
Frontiers in Immunology, Vol. 13
2021
-
Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in murine models
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-19
-
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
Frontiers in Pharmacology, Vol. 12
-
Multi-smart and scalable bioligands-free nanomedical platform for intratumorally targeted tambjamine delivery, a difficult to administrate highly cytotoxic drug
Biomedicines, Vol. 9, Núm. 5
-
Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells
International Immunopharmacology, Vol. 91
-
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 1, pp. 238-247
-
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
Molecular Therapy - Nucleic Acids, Vol. 24, pp. 807-821
-
Tp53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A
International Journal of Molecular Sciences, Vol. 22, Núm. 14
2020
-
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
Frontiers in Immunology, Vol. 11
-
Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS
Clinica Chimica Acta, Vol. 503, pp. 210-217
2019
-
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring)
Clinica Chimica Acta, Vol. 495, pp. 287-293
-
The natural-based antitumor compound T21 decreases survivin levels through potent stat3 inhibition in lung cancer models
Biomolecules, Vol. 9, Núm. 8
2018
-
ANRIL as a genetic marker for cardiovascular events in renal transplant patients – an observational follow-up cohort study
Transplant International, Vol. 31, Núm. 9, pp. 1018-1027
-
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm
International Journal of Antimicrobial Agents, Vol. 51, Núm. 6, pp. 854-861
-
PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
Molecular and Cellular Biochemistry, Vol. 448, Núm. 1-2, pp. 187-197